MedPath

OTSUKA AMERICA PHARMACEUTICAL, INC.

OTSUKA AMERICA PHARMACEUTICAL, INC. logo
🇺🇸United States
Ownership
Subsidiary
Established
1989-01-01
Employees
5K
Market Cap
-
Website
http://www.otsuka-us.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

FDA:10

Drug Approvals

ABILIFY MAINTENA

Approval Date
Feb 13, 2024
FDA

Abilify Asimtufii

Approval Date
Jan 30, 2024
FDA

BUSULFEX

Approval Date
Dec 14, 2023
FDA

Dacogen

Approval Date
Nov 30, 2023
FDA

Abilify MyCite

Approval Date
Oct 16, 2023
FDA

Nuedexta

Approval Date
Oct 13, 2023
FDA

Rexulti

Approval Date
May 15, 2023
FDA

ABILIFY

Approval Date
Nov 30, 2022
FDA

SAMSCA

Approval Date
Nov 9, 2022
FDA

Jynarque

Approval Date
Nov 8, 2022
FDA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath